+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Hairy Cell Leukemia Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Hairy Cell Leukemia Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Skin Cancer Diagnostics Market - Global Strategic Business Report - Product Thumbnail Image

Skin Cancer Diagnostics Market - Global Strategic Business Report

  • Report
  • November 2025
  • 370 Pages
  • Global
From
From
From
Acute Myeloid Leukemia Market Report 2025 - Product Thumbnail Image

Acute Myeloid Leukemia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Myelodysplastic Syndrome Market Report 2025 - Product Thumbnail Image

Myelodysplastic Syndrome Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Refractory Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Gonorrhea Therapeutics Market - Global Strategic Business Report - Product Thumbnail Image

Gonorrhea Therapeutics Market - Global Strategic Business Report

  • Report
  • November 2025
  • 140 Pages
  • Global
From
Loading Indicator